Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arapahoe Chemicals was a pioneering fine chemical manufacturer founded in 1946 in Boulder, Colorado. The company gained a strong reputation for producing high-quality reagents, pharmaceutical intermediates, and specialty organic chemicals, notably Grignard reagents. In 1965, Arapahoe Chemicals was acquired by Syntex Corporation, serving as a critical production site for Syntex's expanding pharmaceutical line. Following Roche's acquisition of Syntex in 1994, the facility transitioned into the Roche Colorado operations. The site was eventually sold to CordenPharma in 2011, where it continues to operate as a major contract manufacturing facility. Arapahoe Chemicals is remembered as a foundational entity in Colorado's biotechnology and chemical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arapahoe Chemicals.